ArticleExperimental dermatology2024

Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study.

Lucía Quintana-Castanedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.